The CABANA Research Trial

Published on May 9, 2012

Mayo Clinic’s Douglas L. Packer, M.D., the principal investigator of the Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) trial, presents an overview of CABANA and encourages eligible patients to enroll as well as medical professionals to refer their atrial fibrillation patients to this important clinical trial. CABANA will help establish the appropriate roles for which therapy (medical versus ablation) works best for treating atrial fibrillation, decreasing the associated symptoms and complications, and how these therapies impact the quality of life of patients. The CABANA study is being conducted in collaboration with the NHLBI, Mayo Clinic, Duke Clinical Research Institute, and the CABANA Research Centers. These centers all over the world are participating in the trial and the 3,000 participants will receive additional attention, access to immediate health care, extra opportunities to monitor their heart rhythm and report their symptoms compared to most patients being treated for atrial fibrillation outside of the CABANA trial. More information on the CABANA trial and how/where to enroll can be found at:

CABANA Trial Updates 2014 – Dr. Douglas Packer, Mayo Clinic